Korean Pharmas To Highlight Lung Cancer Pipeline Progress At AACR

Several South Korean companies are set to present updates on their growing lung cancer pipelines at a major meeting in Chicago this month, underlining the high unmet needs and strong R&D interest in this area by firms in the country.  

lung illustration
KOREAN FIRMS' ONCOLOGY INTEREST GROWING

More from R&D

More from Scrip